W. A. M. Duncan

3.9k total citations · 2 hit papers
23 papers, 3.0k citations indexed

About

W. A. M. Duncan is a scholar working on Molecular Biology, Immunology and Biochemistry. According to data from OpenAlex, W. A. M. Duncan has authored 23 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Immunology and 3 papers in Biochemistry. Recurrent topics in W. A. M. Duncan's work include Mast cells and histamine (7 papers), Receptor Mechanisms and Signaling (4 papers) and Amino Acid Enzymes and Metabolism (3 papers). W. A. M. Duncan is often cited by papers focused on Mast cells and histamine (7 papers), Receptor Mechanisms and Signaling (4 papers) and Amino Acid Enzymes and Metabolism (3 papers). W. A. M. Duncan collaborates with scholars based in United Kingdom and Mexico. W. A. M. Duncan's co-authors include C. Robin Ganellin, J. W. Black, E. Marie Parsons, G. J. DURANT, J. C. EMMETT, Michael E. Parsons, R.W. Brimblecombe, M. E. Parsons, T. Hesselbo and J H Wyllie and has published in prestigious journals such as Nature, Gastroenterology and British Journal of Pharmacology.

In The Last Decade

W. A. M. Duncan

23 papers receiving 2.6k citations

Hit Papers

Definition and Antagonism of Histamine H2-receptors 1972 2026 1990 2008 1972 1973 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Definition and Antagonism of Histamine H2-receptors
    1972 1.8k citations J. W. Black, W. A. M. Duncan et al. Nature profile →
  2. Metiamide — An orally active histamine H2-receptor antagonist
    1973 221 citations J. W. Black, W. A. M. Duncan et al. Inflammation Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W. A. M. Duncan United Kingdom 11 1.3k 1.0k 614 500 402 23 3.0k
J. W. Black United Kingdom 13 1.1k 0.9× 887 0.9× 577 0.9× 468 0.9× 367 0.9× 36 2.6k
Michael E. Parsons United Kingdom 26 1.1k 0.8× 664 0.7× 423 0.7× 350 0.7× 361 0.9× 72 2.3k
Gabriella Coruzzi Italy 26 811 0.6× 702 0.7× 478 0.8× 280 0.6× 262 0.7× 132 2.4k
G. J. DURANT United Kingdom 16 804 0.6× 515 0.5× 272 0.4× 204 0.4× 96 0.2× 37 1.6k
Victor Cohn United States 11 1.4k 1.0× 1.0k 1.0× 486 0.8× 216 0.4× 118 0.3× 30 3.0k
Akira Karasawa Japan 25 857 0.7× 336 0.3× 411 0.7× 251 0.5× 146 0.4× 185 2.7k
H. Mattsson Sweden 34 1.1k 0.8× 200 0.2× 454 0.7× 519 1.0× 1.6k 3.9× 76 3.5k
R.W. Brimblecombe United Kingdom 20 522 0.4× 189 0.2× 155 0.3× 281 0.6× 235 0.6× 69 1.5k
Yves Landry France 34 2.4k 1.9× 1.2k 1.2× 834 1.4× 940 1.9× 339 0.8× 141 4.4k
William Kreutner United States 34 746 0.6× 1.0k 1.0× 2.0k 3.2× 301 0.6× 263 0.7× 91 3.4k

Countries citing papers authored by W. A. M. Duncan

Since Specialization
Citations

This map shows the geographic impact of W. A. M. Duncan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. A. M. Duncan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. A. M. Duncan more than expected).

Fields of papers citing papers by W. A. M. Duncan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. A. M. Duncan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. A. M. Duncan. The network helps show where W. A. M. Duncan may publish in the future.

Co-authorship network of co-authors of W. A. M. Duncan

This figure shows the co-authorship network connecting the top 25 collaborators of W. A. M. Duncan. A scholar is included among the top collaborators of W. A. M. Duncan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. A. M. Duncan. W. A. M. Duncan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Duncan, W. A. M., et al.. (2010). The pharmacology of cimetidine, a new histamine H2‐receptor antagonist. British Journal of Pharmacology. 160(s1). 435P–3. 29 indexed citations
2.
Black, J. W., W. A. M. Duncan, J. C. EMMETT, et al.. (1994). Metiamide—An orally active histamine H2-receptor antagonist. Inflammation Research. 43(3-4). 91–96. 4 indexed citations
3.
Duncan, W. A. M.. (1993). Some decision in the development of cimetidine. Drug Development Research. 30(1). 18–23. 2 indexed citations
4.
Jc, Gillin, et al.. (1980). Intravenous chlorimipramine affects REM cycle in patients with excessive daytime sleepiness and control subjects.. PubMed. 4(1). 35–40. 1 indexed citations
5.
Plaa, Gàbriel L. & W. A. M. Duncan. (1978). Proceedings of the First International Congress on Toxicology : toxicology as a predictive science. Academic Press eBooks. 5 indexed citations
6.
DURANT, G. J., et al.. (1978). Impromidine (SK&F 92676) is a very potent and specific agonist for histamine H2 receptors. Nature. 276(5686). 403–405. 178 indexed citations
7.
Brimblecombe, R.W., W. A. M. Duncan, G. J. DURANT, et al.. (1978). Characterization and development of cimetidine as a histamine H2-receptor antagonist. Gastroenterology. 74(2). 339–347. 159 indexed citations
8.
Brimblecombe, R.W., W. A. M. Duncan, D. A. A. Owen, & M. E. Parsons. (1976). The pharmacology of burimamide and metiamide, two histamine H2-receptor antagonists.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 35(8). 1931–4. 28 indexed citations
9.
Brimblecombe, R.W., W. A. M. Duncan, G. J. DURANT, et al.. (1975). Proceedings: The pharmacology of cimetidine, a new histamine H2-receptor antagonist.. British Journal of Pharmacology. 53(3). 435. 34 indexed citations
10.
Black, J. W., W. A. M. Duncan, J. C. EMMETT, et al.. (1973). Metiamide — An orally active histamine H2-receptor antagonist. Inflammation Research. 3(3). 133–137. 221 indexed citations breakdown →
11.
Black, J. W., et al.. (1972). Definition and Antagonism of Histamine H2-receptors. Nature. 236(5347). 385–390. 1770 indexed citations breakdown →
12.
Duncan, W. A. M., et al.. (1967). Absorption, distribution and metabolism of the anthelmintic methyridine. Biochemical Pharmacology. 16(3). 463–482. 7 indexed citations
13.
Duncan, W. A. M.. (1967). Species variation in drug metabolism.. PubMed. 23(116). 537–41. 1 indexed citations
14.
Black, J. W., W. A. M. Duncan, & R. G. Shanks. (1966). COMPARISON OF SOME PROPERTIES OF PRONETHALOL AND PROPANOLOL. Survey of Anesthesiology. 10(5). 423–423. 4 indexed citations
15.
Duncan, W. A. M.. (1964). Absorption and Distribution of Drugs. Nature. 202(4936). 938–939. 92 indexed citations
16.
Duncan, W. A. M. & R S Morton. (1962). Treatment Of Non-gonococcal Urethritis with I.C.I. 17,025. Sexually Transmitted Infections. 38(2). 64–68. 2 indexed citations
17.
Duncan, W. A. M., et al.. (1961). THE PHARMACOKINETICS OF HALOTHANE (FLUOTHANE) ANAESTHESIA. Survey of Anesthesiology. 5(1). 55–55. 1 indexed citations
18.
Duncan, W. A. M. & J. RAVENTÓS. (1959). THE PHARMACOKINETICS OF HALOTHANE (FLUOTHANE) ANAESTHESIA. British Journal of Anaesthesia. 31(7). 302–315. 51 indexed citations
19.
Duncan, W. A. M.. (1959). THE ESTIMATION OF HALOTHANE IN TISSUES. British Journal of Anaesthesia. 31(7). 316–320. 3 indexed citations
20.
Duncan, W. A. M.. (1959). The Absorption and Distribution of Halothane. Journal of Pharmacy and Pharmacology. 11(Supplement_1). 291T–293T. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. W. Black Breakdown of academic impact, for papers by Michael E. Parsons Breakdown of academic impact, for papers by Gabriella Coruzzi Breakdown of academic impact, for papers by G. J. DURANT Breakdown of academic impact, for papers by Victor Cohn Breakdown of academic impact, for papers by Akira Karasawa Breakdown of academic impact, for papers by H. Mattsson Breakdown of academic impact, for papers by R.W. Brimblecombe Breakdown of academic impact, for papers by Yves Landry Breakdown of academic impact, for papers by William Kreutner
Rankless by CCL
2026